| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 02/04/2004 | EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 02/04/2004 | EP0992495B1 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride |
| 02/03/2004 | US6686470 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| 02/03/2004 | US6686369 α-hydrdroxylic acid derivatives, their production and use |
| 02/03/2004 | US6686368 Inhibitors of factor Xa |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 01/29/2004 | WO2004009556A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 01/29/2004 | WO2004009555A1 5-substituted isoquinoline derivative |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019079 Beta3-Adrenoreceptor agonists, agonist compositions and methods of using |
| 01/29/2004 | US20040019078 Substituted tetrahydroisoquinoline compounds, methods of making, and their use |
| 01/29/2004 | US20040019077 Heterocyclic imines such as N1-(8-sulfonamide-5-isoquinoline)-N2-(3,3-diphenyl-2-propenyl) -ethylenediamine, used for prophylaxis and diagnosis of cancers, diabetes, cardiovascular and nervous system disorders, autoimmune diseases or obesity |
| 01/29/2004 | US20040019049 Substituted quinazolinone compounds |
| 01/29/2004 | US20040018951 Organic catalyst with enhanced solubility |
| 01/29/2004 | US20040018192 Integrin expression inhibitors |
| 01/29/2004 | CA2493234A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 01/29/2004 | CA2493230A1 5-substituted isoquinoline derivative |
| 01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| 01/27/2004 | US6683083 Using less toxic agents such as 1-(1-4-(diphenylmethyl)-piperazinyl)-3-(1-(4-(4-chlorophenyl)-4 -hydroxy)piperidinyl)-2-propanol; inhibiting fibroblast proliferation |
| 01/22/2004 | WO2004007459A2 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
| 01/22/2004 | WO2004007407A2 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 01/22/2004 | US20040014784 Substituted propargylamines |
| 01/21/2004 | CN1469862A 2,2-diphenyl butanamide derivatives and medicines containing the same |
| 01/21/2004 | CN1468853A Tetrahydroisoquinoline derivative as one kind of acid added salt for treating cardiac and cerebral vascular diseases and its prepn |
| 01/20/2004 | CA2284795C Novel pyrimidine derivatives and processes for the preparation thereof |
| 01/15/2004 | WO2004005279A2 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | WO2004004727A1 3,4-dihydroisoquinolin-1-one derivatives as inducers of apoptosis |
| 01/15/2004 | US20040010014 Novel compounds as opioid receptor modulators |
| 01/15/2004 | US20040009994 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions |
| 01/15/2004 | US20040009985 Bicyclo 4.4.0 antiviral derivatives |
| 01/15/2004 | CA2489166A1 Substituted anthranilic amide derivatives and methods of use |
| 01/14/2004 | EP1380573A2 Isoquinolines and preparation thereof |
| 01/14/2004 | EP1379517A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 01/14/2004 | EP1379507A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1134410C Amine derivative, process for producing same, and use thereof as antiarrhythmic medicine |
| 01/08/2004 | WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 01/08/2004 | WO2004002961A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | WO2003047515A3 P2x7 receptor antagonists |
| 01/08/2004 | WO2002080164A9 Optical recording medium |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006069 For therapy inflammatory and immune system disorders such as stroke, myocardial infarction, atherosclerosis, ischemic heart disease, ischemia-reperfusion injury |
| 01/08/2004 | CA2493646A1 Caspase inhibitors and uses thereof |
| 01/07/2004 | EP1377978A2 Optical data carrier whose information layer contains a light-absorbing compound having a number of chromophoric centers |
| 01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377975A2 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness |
| 01/07/2004 | EP1377974A1 Optical data carrier containing a xanthene dye in the information layer thereof as a light-absorbing compound |
| 01/07/2004 | EP1377973A1 Optical data memories containing an axially substituted co-phthalocyanine in the information layer that can be written with light |
| 01/07/2004 | EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377970A1 Optical data carrier containing a cyclizable compound in the information layer |
| 01/07/2004 | EP1377968A2 Optical data carrier that contains a heterocyclic azo dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/07/2004 | CN1465566A Sinomenine Hydrochloride and its compound, synthesis and use |
| 01/07/2004 | CN1133620C Alpha, alpha'-diamino alcohol and preparation process thereof |
| 01/06/2004 | US6673804 Preventing or treating arthritis (particularly osteoarthritis) or inhibiting metastasis, invasion or growth of cancer (particularly breast cancer) |
| 01/02/2004 | EP1374234A1 Optical data support comprising a hemicyanin dye in the information layer as light-absorbing compound |
| 01/02/2004 | EP1374233A1 Optical data carrier that contains a triazacyanine dye as the light-absorbing compound in the information layer g |
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1373212A1 Beta-3-adrenoreceptor agonists, agonist compositions and methods of making and using the same |
| 01/02/2004 | EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 12/31/2003 | WO2004000828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/31/2003 | WO2004000825A1 Novel compounds |
| 12/31/2003 | WO2004000815A1 Acutumine and acutumine compounds, synthesis and use |
| 12/31/2003 | WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators |
| 12/31/2003 | WO2004000295A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
| 12/31/2003 | CA2491214A1 Acutumine and acutumine compounds, synthesis and use |
| 12/31/2003 | CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
| 12/31/2003 | CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators |
| 12/31/2003 | CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/30/2003 | US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide; |
| 12/29/2003 | CA2433983A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 12/25/2003 | US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/25/2003 | US20030236198 For treatment of infections by drug resistant bacteria |
| 12/24/2003 | WO2003106524A1 Compositions for producing aminoplast products and method for producing products from these compositions |
| 12/24/2003 | WO2003106426A1 Compounds, compositions, and methods |
| 12/24/2003 | WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 12/24/2003 | WO2003106405A1 Aspartyl protease inhibitors |
| 12/24/2003 | WO2003072558A3 Arylsulfone derivatives |
| 12/24/2003 | WO2003042135A3 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 12/24/2003 | WO2003040174A3 Substituted amino ketone compounds |
| 12/24/2003 | WO2002028829A3 Peptide deformylase inhibitors |
| 12/24/2003 | CA2489380A1 Compositions for producing aminoplast products and method for producing products from these compositions |
| 12/24/2003 | CA2489367A1 Compounds, compositions, and methods |
| 12/24/2003 | CA2489095A1 Aspartyl protease inhibitors |
| 12/23/2003 | US6667307 HIV protease |
| 12/18/2003 | WO2003104282A2 Immunoadhesin comprising a glycoprotein vi domain |
| 12/18/2003 | WO2003104199A2 Organic catayst with enhanced solubility |
| 12/18/2003 | WO2003103662A2 Inhibitors of glycoprotein vi |
| 12/18/2003 | WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors |
| 12/18/2003 | US20030232846 Caspase inhibitors and uses thereof |
| 12/18/2003 | US20030232808 Sulfonyl derivatives |